Brittany Quagan,Scott W Woods,Albert R Powers
Brittany Quagan
Prevalence and Trends in Suicidal Behavior Among US Military Veterans During the COVID-19 Pandemic [0.03%]
美国退伍军人在COVID-19大流行期间的自杀行为的流行率及变化趋势
Brandon Nichter,Melanie L Hill,Peter J Na et al.
Brandon Nichter et al.
Importance: The COVID-19 pandemic has raised considerable concerns about increased risk for suicidal behavior among US military veterans, who already had elevated rates of suicide before the pandemic. ...
Comparison of Teleintegrated Care and Telereferral Care for Treating Complex Psychiatric Disorders in Primary Care: A Pragmatic Randomized Comparative Effectiveness Trial [0.03%]
初级保健中治疗复杂精神疾病的远程整合护理与远程转诊护理比较研究： pragmatic 随机疗效性试验
John C Fortney,Amy M Bauer,Joseph M Cerimele et al.
John C Fortney et al.
Importance: Only one-third of patients with complex psychiatric disorders engage in specialty mental health care, and only one-tenth receive adequate treatment in primary care. Scalable approaches are critically needed to...
Comparative Study
JAMA psychiatry. 2021 Nov 1;78(11):1189-1199. DOI:10.1001/jamapsychiatry.2021.2318 2021
Effect of Exercise, Escitalopram, or Placebo on Anxiety in Patients With Coronary Heart Disease: The Understanding the Benefits of Exercise and Escitalopram in Anxious Patients With Coronary Heart Disease (UNWIND) Randomized Clinical Trial [0.03%]
运动、艾司西酞普兰或安慰剂对冠心病患者焦虑症状的影响：关于理解冠心病伴发焦虑症患者的运动和艾司西酞普兰治疗效益（UNWIND）的随机临床试验
James A Blumenthal,Patrick J Smith,Wei Jiang et al.
James A Blumenthal et al.
Importance: Anxiety is common among patients with coronary heart disease (CHD) and is associated with worse health outcomes; however, effective treatment for anxiety in patients with CHD is uncertain. ...
Randomized Controlled Trial
JAMA psychiatry. 2021 Nov 1;78(11):1270-1278. DOI:10.1001/jamapsychiatry.2021.2236 2021
Time to Support Extensive Implementation of Shared Decision Making in Psychiatry [0.03%]
该是时候支持精神病学中广泛实施共同决策的时候了
Yaara Zisman-Ilani,Robert M Roth,Lisa A Mistler
Yaara Zisman-Ilani
Examination of Dosing of Antipsychotic Drugs for Relapse Prevention in Patients With Stable Schizophrenia: A Meta-analysis [0.03%]
稳定型精神分裂症患者抗精神病药物预防复发的剂量研究meta分析
Stefan Leucht,Sofia Bauer,Spyridon Siafis et al.
Stefan Leucht et al.
Importance: The doses of antipsychotic drugs needed for relapse prevention in schizophrenia is a debated issue. Objective: To examine d...
A Call to Revise the Diagnosis of Oppositional Defiant Disorder-Diagnoses Are for Helping, Not Harming [0.03%]
重新审视对立违抗性障碍的诊断——诊断是为了帮助而不是伤害
Sourik Beltrán,Lydia Sit,Kenneth R Ginsburg
Sourik Beltrán
Polygenic Risk Scores Derived From Varying Definitions of Depression and Risk of Depression [0.03%]
基于抑郁症不同定义得出的多基因风险评分与抑郁症发病风险的关系
Brittany L Mitchell,Jackson G Thorp,Yeda Wu et al.
Brittany L Mitchell et al.
Importance: Genetic studies with broad definitions of depression may not capture genetic risk specific to major depressive disorder (MDD), raising questions about how depression should be operationalized in future genetic...
Associations Between Schizophrenia Polygenic Liability, Symptom Dimensions, and Cognitive Ability in Schizophrenia [0.03%]
关于精神分裂症多基因易感性、症状维度和认知能力的相关性研究
Sophie E Legge,Alastair G Cardno,Judith Allardyce et al.
Sophie E Legge et al.
Importance: Schizophrenia is a clinically heterogeneous disorder. It is currently unclear how variability in symptom dimensions and cognitive ability is associated with genetic liability for schizophrenia. ...
Contingency Management for Patients Receiving Medication for Opioid Use Disorder: A Systematic Review and Meta-analysis [0.03%]
面向阿片类药物使用障碍患者的药物依从性管理：系统回顾和荟萃分析
Hypatia A Bolívar,Elias M Klemperer,Sulamunn R M Coleman et al.
Hypatia A Bolívar et al.
Importance: Medication treatment for opioid use disorder (MOUD) is efficacious, but comorbid stimulant use and other behavioral health problems often undermine efficacy. ...